Scientists say new liver drug could stop fatty liver disease before it turns deadly

An experimental drug called ION224 is giving fresh hope to millions suffering from MASH, a dangerous fatty liver disease tied to obesity and diabetes. Scientists say the treatment attacks the illness at its source by blocking fat build-up inside the liver, potentially preventing deadly damage before it begins.